You are here

Industry News

Advamed Smart Brief

April 27, 2017
German molecular diagnostics company Epigenomics has accepted a public takeover offer of approximately $186 million from Blit -More
April 27, 2017
A round of funding has brought in an undisclosed amount for Houston-based medical device company Allotrope Medical.  -More
April 27, 2017
Becton Dickinson has granted Roche Holding a nonexclusive license for its patented stochastic labeling technology for multipl -More
April 27, 2017
An Absolute Reports analysis predicts the worldwide lumbar spine fusion market will see a 4.9% compound annual growth rate th -More
April 27, 2017
Pittsburgh-based ALung Technologies has filed an investigational device exemption application with the FDA to conduct a study -More
April 27, 2017
The Monarch airway clearance system, a mobile vest that delivers high-frequency chest wall oscillation, has been launched by  -More
April 27, 2017
European regulators have given Intuitive Surgical CE mark approval for its da Vinci X robotic-assisted surgical system, which -More
April 27, 2017
The Risk-Based Classification of Accessories Act was introduced in the House to streamline regulatory reviews of medical devi -More
April 27, 2017
Applications filed by Abbott and Medtronic to pull their new-generation stents from the Indian market have been rejected by t -More
April 27, 2017
The FDA has given Bausch + Lomb clearance to market its Vitesse, a hypersonic device intended for removal of vitreous.  -More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​